wellrank.ai
Sign In
Estrace logo

Estrace

First cited by AI Jun 11, 2026
estrace.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Estrace, through Aug 13, 2026.

20.0%

Avg position when mentioned: 3.6 · peak 24% on Aug 12

By engine

Where Estrace is strong, and where it is invisible.

  • ChatGPT
    26.7%
  • Google AI
    20.0%
  • Claude
    13.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 105 positive mentions
  • 105 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Estrace

ChatGPTAug 13, 2026, 12:43 UTC
Estrogen patch vs pill: which is safer?

Short answer: for most people who are concerned about blood clots, a transdermal estradiol patch is generally safer than oral estrogen pills. Both relieve menopausal symptoms, but the patch carries a lower risk of venous thromboembolism (VTE) and less adverse effect on liver-produced clotting factors and some lipids because it bypasses first‑pass metabolism in the liver. Why the difference Oral estrogens (Premarin, Estrace) pass through the liver first and raise clotting factors, C‑reactive protein and triglycerides — which increases VTE and possibly stroke risk. Transdermal estradiol (patches or gels such as Vivelle‑Dot, Climara, Minivelle, Alora or gels like EstroGel/Divigel) delivers hormone through the skin and has much smaller effects on those liver factors and on VTE risk. Who should especially consider a patch History of blood clots or known thrombophilia (e.g., factor V Leiden) Obesity Older age or >10 years since menopause (higher baseline vascular risk) Smokers or people with other cardiovascular risk factors Things to know before choosing If you have a uterus, you generally need a progestin in addition to estrogen to prevent endometrial hyperplasia. Options include a levonorgestrel IUD (Mirena — good because it gives local progestin), oral medroxyprogesterone (Provera), micronized progesterone (Prometrium), or a combined transdermal (CombiPatch) in some cases. Both routes can relieve hot flashes and sleep trouble; side effects (breast tenderness, nausea, spotting) depend on dose and formulation. Systemic estrogen is contraindicated in active or recent breast cancer, pregnancy, active liver disease, unexplained vaginal bleeding, or recent VTE/stroke in many cases. If you prefer not to use hormones or have contraindications, nonhormonal options include low‑dose paroxetine (Brisdelle), SNRIs (venlafaxine), gabapentin, or lifestyle measures. Brand examples (FDA‑approved) Transdermal patches: Vivelle‑Dot, Climara, Minivelle, Alora Transdermal gels: EstroGel, Divigel Oral estrogens: Estrace (estradiol), Premarin (conjugated equine estrogens) Combined transdermal: CombiPatch (estradiol + norethindrone acetate) Progestins: Mirena (levonorgestrel IUD), Provera (medroxyprogesterone), Prometrium (micronized progesterone) Next step Talk with your clinician (primary care or gynecologist) about your personal risk factors (age, BMI, smoking, history of clots, migraines with aura, family history of thrombosis). If you want telehealth options, services such as Maven Clinic or your local women’s health clinic can evaluate you and prescribe appropriate, FDA‑approved formulations and arrange follow‑up. If you’d like, tell me your age and relevant medical history (clot history, smoking, uterus status, breast cancer history) and I can give a more personalized comparison.

Mentioned in position 2 of 14

Read full answer with sources →
Google AIAug 13, 2026, 12:43 UTC
Estrogen patch vs pill: which is safer?

When comparing estrogen patches and pills for safety, the general consensus among medical professionals is that estrogen patches are often considered safer, particularly for certain cardiovascular risks. Here's a breakdown of why, along with specific brand examples: Estrogen Patches (Transdermal Estrogen) Why they are generally considered safer: Estrogen patches deliver estrogen directly into your bloodstream through your skin, bypassing the liver's "first-pass metabolism." This is the key difference that impacts safety. When estrogen goes directly into the bloodstream, it: Lower Risk of Blood Clots (DVT/PE): It has less impact on the liver's production of clotting factors (like Factor VII, Protein C, Protein S), which means a significantly lower risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Lower Risk of Stroke: Studies suggest a reduced risk of stroke compared to oral estrogen, especially in women with certain risk factors. Less Impact on Triglycerides: Transdermal estrogen does not significantly raise triglyceride levels, which is beneficial for cardiovascular health. Less Impact on Blood Pressure: It may have a more neutral effect on blood pressure compared to oral estrogen. Less Impact on the Gallbladder: The liver processing of oral estrogen can increase the risk of gallbladder disease; patches avoid this. Specific Patch Brands: Vivelle-Dot, Minivelle, Climara, Estraderm, Alora: These are common transdermal estrogen patches. They typically deliver bioidentical estradiol and are changed every few days or once a week. They are often preferred for women with a higher risk of blood clots, stroke, or other cardiovascular issues. Estrogen Pills (Oral Estrogen) Why they carry slightly higher risks for some conditions: Oral estrogen pills are absorbed through the digestive system and then go directly to the liver before circulating throughout the body. This "first-pass metabolism" in the liver leads to: Increased Risk of Blood Clots (DVT/PE): The liver processes oral estrogen in a way that increases the production of certain clotting factors, leading to a higher risk of DVT and PE. Increased Risk of Stroke: Oral estrogen has been associated with a slightly higher risk of stroke, particularly in older women or those with pre-existing risk factors. Increased Triglycerides: Oral estrogen can significantly raise triglyceride levels. Potential for Blood Pressure Increase: Some women may experience an increase in blood pressure with oral estrogen. Increased Risk of Gallbladder Disease: The liver processing can increase the risk of developing gallstones or gallbladder inflammation. Specific Pill Brands: Estrace, Menest: These are oral estradiol pills, which are bioidentical and often considered a good option for women without the higher risk factors mentioned above. Premarin: This is conjugated equine estrogen, derived from pregnant mare's urine. It's one of the oldest forms of HRT. Activella, Angeliq, Combipatch: These are examples of combined* oral or transdermal HRT (estrogen + progestin), often prescribed for women with a uterus to prevent uterine lining overgrowth. When Patches Are Strongly Preferred (and why) Your doctor will likely recommend a patch over a pill if you have: A history of blood clots (DVT or PE) – The patch significantly lowers recurrence risk.* A history of stroke or transient ischemic attack (TIA) – The patch avoids the increased stroke risk of oral forms.* Known clotting disorders (e.g., Factor V Leiden) – Essential to minimize clotting factor activation.* High risk factors for cardiovascular disease (e.g., smoking, uncontrolled high blood pressure, high cholesterol/triglycerides, obesity) – Minimizes additional strain on the cardiovascular system.* Migraine with aura – This significantly increases stroke risk with oral estrogen, making patches the safer choice.* Active liver disease or gallbladder issues – Bypasses liver metabolism.* The Bottom Line: Individualized Decision While estrogen patches often have a more favorable safety profile regarding blood clots and stroke risk, especially for women with certain pre-existing conditions or risk factors, the "safest" option ultimately depends on your individual health profile, medical history, and personal preferences. It is crucial to have a detailed discussion with your doctor or gynecologist. They will assess your risks and benefits, help you weigh the options, and recommend the most appropriate form and dosage of estrogen for you.

Mentioned in position 6 of 11

Read full answer with sources →
ChatGPTAug 12, 2026, 12:15 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” means the hormone molecule is chemically identical to the hormone your body makes (usually estradiol and/or micronized progesterone). “Standard” or conventional HRT includes FDA‑approved products that may be either bioidentical (e.g., estradiol, micronized progesterone) or non‑bioidentical (e.g., conjugated equine estrogens, synthetic progestins). The main practical differences are in regulation, quality control, evidence about safety and effectiveness, and how the product is prepared (manufactured vs compounded). Key points 1) What “bioidentical” usually means Refers to hormones with the same chemical structure as human hormones (eg, 17β‑estradiol, progesterone). Available both as FDA‑approved manufactured products and as custom‑made compounded preparations from compounding pharmacies. Examples of FDA‑approved “bioidentical” products: Estrace (oral estradiol), Vivelle‑Dot/Climara/Alora (estradiol patches), EstroGel/Evamist (topical estradiol), and Prometrium (micronized progesterone). 2) What “standard” HRT includes FDA‑approved options with known dosing, manufacturing standards, and clinical trial data. Some are bioidentical (see above); others are not (eg, Premarin — conjugated equine estrogens; Prempro — conjugated estrogens + medroxyprogesterone). Provera (medroxyprogesterone acetate) is a commonly used synthetic progestin. 3) Regulation and quality control FDA‑approved products: manufactured under strict quality controls, have standardized dosing, and have been studied for efficacy/safety. Compounded bioidentical hormone therapy (custom mixes such as “bi‑est” or “tri‑est” or individualized doses): not FDA‑approved, variable potency and purity, limited large‑scale safety data. The FDA and medical societies warn about these limitations. 4) Evidence on safety and risks Risks such as venous thromboembolism, stroke, and (in some studies) breast cancer vary by hormone type, dose, route (oral vs transdermal), patient age and how long since menopause. For example, transdermal estradiol may have lower clot risk than oral estrogen in some studies. The Women’s Health Initiative (WHI) raised important safety questions about some HRT combinations (esp. conjugated estrogens + medroxyprogesterone). That evidence applies to specific products/doses and to average results in a population — individual risks vary. There is no convincing high‑quality evidence that compounded bioidentical mixes are safer or more effective than FDA‑approved HRT. 5) Testing and monitoring Routine salivary “hormone level” testing for tailoring HRT is not supported by good evidence; saliva tests are unreliable for guiding therapy. Blood estradiol or progesterone tests can be useful in specific clinical contexts but are not required for most standard dosing decisions. Follow clinical symptoms and routine safety monitoring (blood pressure, lipid profile, mammography as indicated). 6) Practical pros and cons FDA‑approved HRT: consistent dosing, quality control, evidence base — generally recommended as first choice. Examples: Estrace, Vivelle‑Dot, Climara, Prometrium, Premarin/Prempro (when those specific hormone formulations are chosen). Compounded bioidentical HRT: may offer customized doses or delivery forms; may be used when an individual truly cannot use available manufactured products. Downsides: variable quality, cost, limited data, insurance may not cover. Recommendations (what you can do next) Talk with a clinician experienced in menopause care (OB/GYN, endocrinologist, or a provider affiliated with the North American Menopause Society). If you want a telemedicine option, services such as Mayo Clinic online consults, Maven Clinic, or local women’s health clinics can connect you to specialists. Prefer FDA‑approved products when possible (examples: Vivelle‑Dot, Climara, Estrace, EstroGel, Prometrium) because of known dosing and safety data. If a compounded product is being considered, use a reputable compounding pharmacy accredited by USP/NAPRA or your local board of pharmacy and discuss the limited evidence and risks. Discuss your medical history (age, time since menopause, clotting history, breast cancer risk, cardiovascular risk) to choose type, dose, and route that best balances symptom relief and safety. Where to read reliable guidance North American Menopause Society (menopause.org) — clinical position statements and patient info. U.S. Food and Drug Administration — consumer updates on compounded bioidentical hormones. Mayo Clinic and American College of Obstetricians & Gynecologists patient information pages. If you want, tell me: your main symptoms, age/time since menopause, and any relevant medical history (blood clots, breast cancer, heart disease) and I can outline the specific pros/cons of particular FDA‑approved options that would commonly be considered for someone like you.

Mentioned in position 1 of 13

Read full answer with sources →
Google AIAug 12, 2026, 12:15 UTC
Bioidentical hormones vs standard HRT: what is the difference?

That's a fantastic and very common question! The terms "bioidentical hormones" and "standard HRT" can be confusing, as there's a significant overlap and some key differences, especially in how they are regulated and prescribed. Let's break it down: What is "Standard HRT" (Conventional Hormone Replacement Therapy)? Standard HRT refers to hormone medications that have been approved by the FDA for treating menopausal symptoms and preventing conditions like osteoporosis. These hormones come in standardized doses, undergo rigorous testing for safety and efficacy, and are manufactured in highly regulated facilities. Key Characteristics: Chemical Structure: Can include hormones that are synthetic (chemically altered from human hormones, e.g., medroxyprogesterone acetate in Provera). Can also include hormones that are bioidentical (chemically identical to hormones naturally produced by the human body, e.g., estradiol, micronized progesterone). Can be animal-derived (e.g., conjugated equine estrogens in Premarin). Regulation: FDA-approved. This means they have undergone extensive clinical trials to prove their safety and effectiveness for their intended uses. Manufacturing: Produced by pharmaceutical companies under strict quality control. Dosage: Standardized doses are available (e.g., 0.5mg, 1mg, 2mg). Examples (Common Brand Names): Estrogens: Premarin (conjugated equine estrogens - animal-derived, not bioidentical) Estrace, Vivelle-Dot, Climara, Estrogel, Divigel (all contain estradiol, which is* bioidentical, but in an FDA-approved formulation) Progestins: Provera (medroxyprogesterone acetate - synthetic progestin, not bioidentical progesterone) Prometrium (micronized progesterone - is* bioidentical progesterone, but in an FDA-approved formulation) Combined HRT: Prempro (Premarin + Provera) What are "Bioidentical Hormones" (BHRT)? The term "bioidentical" refers specifically to the chemical structure of the hormone. It means the hormone molecule is exactly the same as the hormone molecule produced naturally by the human body (e.g., estradiol, progesterone, testosterone, DHEA). There are two main categories of bioidentical hormones: FDA-Approved Bioidentical Hormones: These are chemically identical to human hormones and are manufactured and regulated just like any other standard prescription drug. They come in standard doses and have proven safety and efficacy. Examples: Estradiol: Found in Estrace (oral), Vivelle-Dot, Climara (patches), Estrogel, Divigel (gels/sprays). Micronized Progesterone: Found in Prometrium (oral capsules). Crucially, these are considered "standard HRT" because they are FDA-approved. Compounded Bioidentical Hormones (cBHRT): These are custom-made by a compounding pharmacy based on a doctor's prescription. They use bioidentical hormone powders (often derived from plant sources like yams or soy, then chemically altered to become human-identical hormones like estradiol or progesterone). Key Characteristics of Compounded BHRT: Chemical Structure: Chemically identical to human hormones. Regulation: NOT FDA-approved. The individual hormone powders are FDA-approved, but the custom-compounded final product* is not. This means their safety, efficacy, purity, and consistency are not as rigorously tested as FDA-approved drugs. Manufacturing: Prepared in a compounding pharmacy, which may have varying levels of quality control compared to large pharmaceutical manufacturers. Dosage: Often promoted as "customized" to an individual's hormone levels (though the clinical utility of this "customization" is debated by mainstream medical organizations). They can come in unique combinations or dosages not available in FDA-approved products. Delivery Methods: Often delivered via transdermal creams, gels, troches (lozenges), or subdermal pellets. Marketing: Often marketed as "natural," "safer," or "more personalized" than conventional HRT. Lack of Research: There is generally a lack of large-scale, peer-reviewed studies to support the safety and efficacy of compounded* BHRT products compared to FDA-approved HRT. Summary of Key Differences: Feature "Standard HRT" (Conventional) "Bioidentical Hormones" (BHRT) Chemical Structure Can be synthetic, animal-derived, or bioidentical. Chemically identical to hormones produced by the human body (e.g., estradiol, progesterone). FDA Approval YES, for all specific products. YES for FDA-approved bioidenticals (e.g., Estrace, Prometrium). NO for compounded BHRT. Regulation Highly regulated, standardized doses, proven safety/efficacy. Highly regulated for FDA-approved forms. Less regulated for compounded forms. Manufacturing Large pharmaceutical companies with strict QC. Large pharma for FDA-approved forms. Compounding pharmacies for compounded forms. Research/Evidence Extensive clinical trials and long-term data (e.g., WHI study data). Extensive for FDA-approved bioidenticals. Limited for compounded BHRT. "Natural" Claims Less commonly claimed (though many contain bioidentical hormones). Often marketed as "natural," "safer," "customized." Examples (Brands) Premarin, Provera, Estrace, Vivelle-Dot, Prometrium, Prempro. FDA-approved: Estrace, Vivelle-Dot, Prometrium. Compounded: No specific brands (custom). What to Consider When Choosing: Safety and Efficacy: FDA-approved hormones (whether synthetic or bioidentical) have the most robust evidence for safety and efficacy at specific doses. Compounded BHRT lacks this level of evidence. Individual Needs: Hormone therapy should always be personalized, regardless of the type. Your doctor will consider your symptoms, medical history, and risk factors. Physician Expertise: Many mainstream medical organizations (like the American College of Obstetricians and Gynecologists, The Endocrine Society, and The North American Menopause Society) recommend FDA-approved hormone therapies due to their proven safety, purity, and efficacy. They caution against compounded BHRT due to lack of regulation and research. Cost: Compounded BHRT is often more expensive and may not be covered by insurance. In essence: You can receive bioidentical hormones that are FDA-approved (like estradiol in a patch or oral micronized progesterone in Prometrium). These are considered standard HRT because they are regulated and tested. The term "bioidentical hormones" becomes more controversial when it refers to the custom-mixed, unregulated products from compounding pharmacies. Recommendation: If you are considering hormone therapy, it is crucial to have an open and thorough discussion with a board-certified gynecologist or endocrinologist. They can help you understand the most appropriate, safest, and most effective options for your specific situation, based on the latest scientific evidence. They can guide you through the pros and cons of FDA-approved options, including those that are bioidentical, and address any concerns you have about compounded formulations.

Mentioned in position 3 of 9

Read full answer with sources →
ClaudeAug 12, 2026, 12:15 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT Traditional hormone replacement therapy uses hormones that may be: Synthetic (chemically similar but not identical to human hormones) Animal-derived (like Premarin, made from pregnant mare urine) FDA-approved with established safety data Common brands: Premarin, Prempro, Provera Bioidentical Hormones Hormones with a molecular structure identical to those your body naturally produces, derived typically from plant sources (soy or yam). Two Types: FDA-approved bioidentical options: Estrace (estradiol) Prometrium (progesterone) Vivelle-Dot (estradiol patch) Bijuva (combined pill) Compounded bioidentical hormones: Custom-mixed by compounding pharmacies Not FDA-approved for safety/efficacy Marketed heavily but have less regulatory oversight Key Considerations Most mainstream doctors prefer FDA-approved bioidenticals as a middle ground Major medical organizations (ACOG, NAMS) are cautious about compounded versions Consult your doctor or a menopause specialist - services like Midi Health or Alloy Women's Health offer expert guidance The term "bioidentical" is sometimes used as a marketing term, so professional guidance matters greatly here.

Mentioned in position 4 of 9

Read full answer with sources →
ChatGPTAug 11, 2026, 13:17 UTC
How much does BHRT cost per month and does insurance ever cover it?

Short answer Typical out-of-pocket cost for BHRT varies widely but expect roughly $50–$700 per month for medications/therapy plus one-time or periodic costs for testing and visits. Insurance sometimes covers FDA‑approved hormone products (patches, pills, gels); it rarely covers compounded (custom) BHRT. Coverage depends on your plan, state, and exact product. What drives the cost Type of therapy: Compounded creams, capsules or troches: ~$50–$300+/month. (Price varies by compound, dose, and pharmacy.) FDA‑approved products (estradiol patches/gels, micronized progesterone): often $20–$250/month (with insurance usually less; without insurance could be higher). Pellets (inserted every 3–6 months): $400–$2,000 per insertion (~$75–$667/month averaged). Injections: ~$30–$150/month depending on drug/dosing. Testosterone (women): compounded options or off‑label use vary ~$50–$300/month; male testosterone products like AndroGel are usually more. Up‑front and ongoing costs: initial consult $100–$400+, lab testing $100–$400+ (baseline hormones, metabolic panel, thyroid), follow‑up visits $50–$250 each. Some clinics charge procedural fees for pellet insertion or removal. Insurance — what to expect FDA‑approved HRT: Many insurers cover prescription estradiol patches/gels/pills and micronized progesterone (Prometrium) when used for approved indications; coverage level depends on your plan’s formulary and copay tiers. Compounded BHRT: Insurance companies commonly refuse payment for compounded/customized hormones or require a strong medical justification and prior authorization. Medicare/Medicaid/private plans: rules differ. Medicare Part D may cover FDA‑approved hormone drugs but typically not compounded products. Always check your specific plan. How to verify: call member services, give the specific drug name (or NDC) or ask whether “compounded hormones” or the brand you want are on the formulary; ask about prior authorization and expected copays. How to lower cost Use FDA‑approved products that are on your plan’s formulary when possible. Compare retail vs. mail‑order pharmacies. Use discount programs like GoodRx or manufacturer coupons for branded products. Ask about generic equivalents (e.g., estradiol generics, micronized progesterone generic). Ask clinics for a full cost estimate (medication + labs + visits + procedures) before starting. Brands/services to consider (examples and why) Vivelle‑Dot, Climara (estradiol patches) — widely used, FDA‑approved; more likely to be covered by insurance than compounded patches. Estrace (estradiol tablets) — common oral estradiol prescription; available as generic. Prometrium (micronized progesterone) — FDA‑approved “bioidentical” progesterone (often covered). AndroGel (testosterone gel) — commonly prescribed testosterone gel (coverage varies; typically for men). BioTE — a widely known clinic/network that provides pellet BHRT; choose if you’re specifically considering pellet therapy and want a clinic that specializes in it. Wedgewood Pharmacy or Empower Pharmacy — examples of reputable compounding pharmacies used by many BHRT providers (if you need compounded formulations). LabCorp or Quest Diagnostics — large national labs for baseline and follow‑up hormone testing. GoodRx — to compare cash prices and get coupons. Next steps (practical) Talk with your primary care doctor, OB/GYN or an endocrinologist about symptoms and goals. Ask the clinic/telehealth service for a written cost estimate (meds, labs, visits, pellet insertion if applicable). Call your insurer’s member services and ask about coverage for the specific drug name (and whether compounded hormones are covered). Compare pricing (insurance vs GoodRx vs mail‑order) and consider starting with FDA‑approved options if you want better odds of coverage. If you want, tell me whether you’re considering pellets, creams, patches, or pills (or if you’re male vs female), your insurance type (private, Medicare, Medicaid, none), and I can give a tighter cost estimate and name likely-covered products for your situation.

Mentioned in position 4 of 11

Read full answer with sources →

TL;DR

Estrace is a brand of estradiol, a bioidentical estrogen produced by pharmaceutical manufacturer Allergan (now part of AbbVie), used primarily to treat symptoms of menopause and other estrogen-deficiency conditions. The brand is available as an oral tablet and as a vaginal cream. According to WellRank's latest index, Estrace ranks fifth in the Menopause and women's health category with 20% AI visibility and sixteenth in BHRT with 13% visibility, placing it among the most consistently cited hormone therapy brands in AI-generated answers.

Company Overview

Estrace is a branded pharmaceutical product rather than an independent company; its formulations have been owned by several pharmaceutical entities over the years, most recently falling under AbbVie following its acquisition of Allergan. The product is sold through licensed pharmacies and healthcare providers under a traditional prescription drug model. Allergan developed and marketed a broad portfolio of women's health products, and Estrace has been a long-standing entry in that portfolio.

Product Features

  • Estrace oral tablets (estradiol 0.5 mg, 1 mg, and 2 mg) for systemic menopause symptom relief
  • Estrace vaginal cream for treating vaginal atrophy and urogenital symptoms of menopause
  • Bioidentical estradiol formulation chemically identical to endogenous human estrogen
  • Available by prescription through retail and specialty pharmacies
  • FDA-approved hormone therapy with an established clinical track record

Target Market

Estrace primarily serves perimenopausal and postmenopausal women in the United States who require estrogen replacement therapy to manage hot flashes, vaginal atrophy, and other estrogen-deficiency symptoms. It is also indicated for certain cases of female hypogonadism and prevention of postmenopausal osteoporosis. The brand is distributed throughout the US market via the traditional prescription pharmacy channel.

Buyer Personas

  • A perimenopausal woman in her late 40s working with a gynecologist to manage worsening hot flashes and sleep disruption.
  • A postmenopausal woman in her 50s or 60s seeking localized vaginal estrogen therapy for dryness and discomfort.
  • A younger woman with surgically induced menopause who requires systemic estrogen replacement at a relatively early age.
  • A patient transitioning from a compounded bioidentical product to an FDA-approved branded estradiol option at her provider's recommendation.

Funding & Performance

Estrace is a prescription pharmaceutical product sold by AbbVie, a publicly traded company (NYSE: ABBV). Revenue attributable specifically to the Estrace brand is not broken out in AbbVie's public financial disclosures.

Recent Developments

The broader hormone replacement therapy landscape has shifted meaningfully following updated guidance from regulatory and health bodies that have revisited earlier, more restrictive positions on HRT use, a development covered in an FDA press announcement on revised HRT warnings. This regulatory context has renewed clinician and patient interest in established estradiol brands like Estrace. Academic literature, such as a BCMJ review of HRT in older women, has also contributed to broadening the perceived eligible population for estrogen therapy.

Competitive Landscape

Estrace competes directly with other estradiol delivery formats and branded hormone therapies that AI engines frequently mention alongside it, including the transdermal patches Vivelle-Dot and Climara, the vaginal ring Estring, and the localized vaginal tablet Vagifem. It also appears in AI answers alongside progestogen products such as Prometrium and Provera, reflecting how clinicians often discuss combination regimens. Premarin, a conjugated equine estrogen product, represents the main non-bioidentical competitor in AI co-mention patterns. Resources like GoodRx's overview of bioidentical hormone therapy frequently group Estrace with these alternatives when comparing options for menopausal women.

Estrace vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Estrace logo
EstraceThis brand
#5
20.0%
Vivelle-Dot logo
Vivelle-Dot

192 shared answers

#3
22.2%
Climara logo
Climara

160 shared answers

#12
17.8%
Prometrium logo
Prometrium

159 shared answers

#10
17.8%
Premarin logo
Premarin

114 shared answers

#9
17.8%

Email me when overtakes Estrace

One email the day the ranks flip. Nothing else.

User Sentiment

Of the 210 AI mentions tracked by WellRank, 105 are positive and 105 are neutral, with zero mixed or cautious mentions, indicating that AI engines present Estrace in a consistently favorable or matter-of-fact clinical light without notable reservations. This split likely reflects the brand's FDA-approved status and its long-standing use in evidence-based prescribing guidelines. Sources such as the Menopause Clinic's treatment cost schedule and Medivera Rx's BHRT cost guide cite the brand in informational contexts that reinforce its credibility.

Pricing

Estrace is a prescription product; retail pricing varies by pharmacy, dosage form, and whether a patient uses insurance or a discount program. Generic estradiol tablets are widely available and are typically less expensive than the branded Estrace product. Exact out-of-pocket costs are not published by the manufacturer and depend heavily on insurance coverage, though cost-comparison resources such as Asheville Rx's BHRT cost breakdown and Live Revital's BHRT pricing guide provide general context for where branded estradiol products sit in the broader HRT cost landscape.

Sources cited around Estrace

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Estrace weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Estrace? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.